Millennium Management’s Latigo Biotherapeutics LTGO Stock Holding History
Bought
Maintained
Sold
Other funds holding LTGO
Millennium Management's LTGO Position: Q3 2026 in Review
Millennium Management opened a new position in Latigo Biotherapeutics (LTGO) in Q3 2026: 83,203 shares worth $1.39M. The stake represents ﹤0.01% of the portfolio and ranks #4209 among its holdings.
58 funds tracked by Wall St. Rank hold LTGO as of Q3 2026.
- Millennium Management held 83,203 shares of Latigo Biotherapeutics worth $1.39M as of Q3 2026.
- Latigo Biotherapeutics was a new Millennium Management position in Q3 2026.
- Latigo Biotherapeutics made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #4209 holding.
- 58 funds tracked by Wall St. Rank held Latigo Biotherapeutics as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.